Cognex (NASDAQ:CGNX) Given Buy Rating at Needham & Company LLC

Key Points

• Needham reiterated a “Buy” rating on Cognex and set an $80 price target, implying 33.56% upside from the prior close. The analyst consensus remains “Moderate Buy,” with an average target of $75.64.
• Cognex reported quarterly EPS of $0.45, beating estimates of $0.42, while revenue rose 16.9% year over year to $291.26 million. The company projected fiscal 2026 EPS of $1.64–$1.68.
• Cognex shares opened at $59.90 after declining 6.7%; institutional investors own approximately 88.12% of the stock.

Cognex (NASDAQ:CGNX - Get Free Report)'s stock had its "buy" rating reiterated by equities research analysts at Needham & Company LLC in a note issued to investors on Tuesday, Benzinga reports. They presently have a $80.00 price target on the scientific and technical instruments company's stock. Needham & Company LLC's price objective points to a potential upside of 33.56% from the stock's previous close.

Other research analysts also recently issued research reports about the stock. The Goldman Sachs Group reiterated a "buy" rating and issued a $91.00 price objective on shares of Cognex in a research report on Friday, August 7th. DA Davidson set a $65.00 target price on Cognex and gave the company a "neutral" rating in a research report on Monday, August 10th. Seaport Research Partners set a $75.00 price target on Cognex in a research note on Tuesday, May 26th. Truist Financial upped their price target on Cognex from $71.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 7th. Finally, Citigroup reiterated a "neutral" rating and set a $74.00 price target (up from $72.00) on shares of Cognex in a research report on Friday, August 7th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $75.64.

Cognex Trading Down 6.7%

Cognex stock opened at $59.90 on Tuesday. The firm has a market cap of $10.08 billion, a PE ratio of 58.16 and a beta of 1.49. Cognex has a 12 month low of $34.60 and a 12 month high of $72.88. The stock's 50 day simple moving average is $63.04 and its two-hundred day simple moving average is $60.08.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The firm had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. During the same period in the previous year, the firm earned $0.25 EPS. The business's quarterly revenue was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities research analysts forecast that Cognex will post 1.68 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CGNX. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of Cognex during the 2nd quarter worth about $26,000. Rakuten Securities Inc. purchased a new stake in Cognex in the 2nd quarter valued at about $32,000. Transamerica Financial Advisors LLC acquired a new position in Cognex in the second quarter valued at about $32,000. Elevation Wealth Partners LLC boosted its stake in Cognex by 635.4% during the second quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock worth $35,000 after buying an additional 413 shares during the period. Finally, FNY Investment Advisers LLC purchased a new position in Cognex during the second quarter worth about $45,000. 88.12% of the stock is owned by hedge funds and other institutional investors.

About Cognex

Cognex Corporation NASDAQ: CGNX develops machine vision technologies that help businesses automate inspection, identification, measurement and guidance tasks. Its systems enable manufacturing and logistics operations to analyze images and make decisions about products, components and packages.

The company's product portfolio includes industrial cameras, vision sensors, barcode readers, three-dimensional vision systems and machine vision software. Cognex also offers artificial intelligence and deep-learning tools designed to address complex inspection and classification applications, along with engineering, implementation and support services.

Founded in 1981 by Robert J.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.